Patents by Inventor Damon Papac

Damon Papac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARF6 inhibitors and related methods
    Patent number: 11414442
    Abstract: Methods of treating vascular leak, vascular inflammation, angiogenesis, ocular disorders, and/or inflammatory disorders in a patient are provided. The methods can include administering an ADP-ribosylation factor 6 (ARF6) inhibitor to the patient. The present disclosure also relates to new chemical entities and pharmaceutical compositions including ARF6 inhibitors. The ARF6 inhibitor may be a prodrug of an ARF6 inhibitor.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: August 16, 2022
    Assignee: Navigen, Inc.
    Inventors: Ashok Bajji, Kirill Ostanin, Alan Mueller, Damon Papac
  • ARF6 INHIBITORS AND RELATED METHODS
    Publication number: 20210017201
    Abstract: Methods of treating vascular leak, vascular inflammation, angiogenesis, ocular disorders, and/or inflammatory disorders in a patient are provided. The methods can include administering an ADP-ribosylation factor 6 (ARF6) inhibitor to the patient. The present disclosure also relates to new chemical entities and pharmaceutical compositions including ARF6 inhibitors. The ARF6 inhibitor may be a prodrug of an ARF6 inhibitor.
    Type: Application
    Filed: February 21, 2020
    Publication date: January 21, 2021
    Inventors: Ashok Bajji, Kirill Ostanin, Alan Mueller, Damon Papac
  • Quinazolinone compounds as calcilytics
    Publication number: 20060052345
    Abstract: Various calcilytic compounds and pharmaceutical compositions containing these compounds are disclosed. Calcilytic compounds are compounds capable of inhibiting calcium receptor activity. Techniques which can be used to obtain calcilytic compounds and uses of calcilyitc compounds as calcium receptor antagonists are also disclosed.
    Type: Application
    Filed: November 4, 2003
    Publication date: March 9, 2006
    Applicant: NPS Pharmaceuticals, Inc.
    Inventors: Irina Shcherbakova, Manuel Balandrin, John Fox, William Heaton, Rebecca Conklin, Damon Papac